Charles River Laboratories CRL Deferred Tax Asset, Valuation Allowance, Reductions For Disposals, Restructuring
Deferred Tax Asset, Valuation Allowance, Reductions For Disposals, Restructuring at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept crl:DeferredTaxAssetValuationAllowanceReductionsForDisposalsRestructuring.
The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's deferred tax asset, valuation allowance, reductions for disposals, restructuring.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's deferred tax asset, valuation allowance, reductions for disposals, restructuring?
- Charles River Laboratories (CRL) reported deferred tax asset, valuation allowance, reductions for disposals, restructuring of $0 in Q4 2025.
- How has Charles River Laboratories's deferred tax asset, valuation allowance, reductions for disposals, restructuring changed year-over-year?
- Charles River Laboratories's deferred tax asset, valuation allowance, reductions for disposals, restructuring decreased by 100.0% year-over-year, from $469.25K to $0.
- What does deferred tax asset, valuation allowance, reductions for disposals, restructuring mean?
- The decrease in the valuation allowance for tax assets due to selling business units or restructuring.
- How do you interpret deferred tax asset, valuation allowance, reductions for disposals, restructuring?
- Reductions often signal a cleanup of the balance sheet or a change in the tax profile following a divestiture.
- How does deferred tax asset, valuation allowance, reductions for disposals, restructuring compare across companies?
- Relevant for companies undergoing significant M&A or portfolio optimization.